Skip to content

Insider · CIK 0001744816

Paul Elliot Mann

ceochairofficerdirectorowner

Files at ASPI (ASP Isotopes Inc.). First filing Apr 17, 2025, latest Sep 4, 2026.

Paul Elliot Mann files SEC Form 4 as CEO, chair, director and 10% owner at ASPI (ASP Isotopes Inc.). Since Apr 17, 2025, Paul Elliot Mann has reported 0 open-market buys worth $0 and 7 open-market sells worth $13M, the latest filed on Sep 4, 2026.

A track record needs three past buys with six months of prices behind them; Paul Elliot Mann has 0, so none is measured yet.

The newest scored trade: sold $999k of ASPI on Sep 2, 2026, filed Sep 4, 2026, scored 45 (moderate), under a 10b5-1 plan. In the last 12 months: 0 buys worth $0 and 5 sells worth $6.0M.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 7
$0 bought, $13M sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

ASPI: ASP Isotopes Inc.

ASPIOct 9, 2026 · close 2.65

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
45Moderate
ASPIsell 310b5-1
ASP Isotopes Inc.
$999k
251,275 shares
-3%-
38Weak
ASPIsell 210b5-1
ASP Isotopes Inc.
$2.0M
251,275 shares
-3%+97% from low-43% from high
31Weak
ASPIsell 210b5-1
ASP Isotopes Inc.
$881k
162,153 shares
-2%+40% from low-61% from high
32Weak
ASPIsell 210b5-1
ASP Isotopes Inc.
$933k
162,153 shares
-2%+42% from low-60% from high
28Weak
ASPIsell 210b5-1
ASP Isotopes Inc.
$1.1M
162,500 shares
-2%+85% from low-48% from high
30Weak
ASPIsell 410b5-1
ASP Isotopes Inc.
$1.4M
162,153 shares
-2%+238% from low-24% from high
43Moderate
ASPIsell 210b5-1
ASP Isotopes Inc.
$5.3M
950,000 shares
-11%+127% from low-35% from high

Planned sales

Form 144 notices this insider filed before selling restricted or control stock, newest first.

FiledCompanySharesValueSale datePast 3 months
Mar 2, 2026 ASPI
ASP Isotopes Inc.
162,153
0.15% of outstanding
$866kMar 2, 2026none
Nov 25, 2025 ASPI
ASP Isotopes Inc.
112,500
0.10% of outstanding
$731kNov 15, 2025$1.4M
Sep 8, 2025 ASPI
ASP Isotopes Inc.
8,438
0.01% of outstanding
$69kSep 8, 2025none
Apr 15, 2025 ASPI
ASP Isotopes Inc.
950,000
1.32% of outstanding
$6.0MApr 15, 2025none

Transactions

Every row this insider has filed, 23 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Sep 2, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,758$3.91$327k9,496,08739 d ago
Sep 3, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,758$3.92$328k9,412,32939 d ago
Sep 4, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,759$4.10$343k9,328,57039 d ago
May 28, 2026ASPI
ASP Isotopes Inc.
AGrant or award
Common Stock10b5-1
+2,233,555--9,830,940Jun 3, 2026
Jun 1, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,758$7.88$660k9,747,182Jun 3, 2026
Jun 2, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,758$8.29$694k9,663,424Jun 3, 2026
Jun 3, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-83,759$7.76$650k9,579,845Jun 3, 2026
Mar 2, 2026ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
+162,153$5.44$881k7,597,385Mar 2, 2026
Dec 1, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-162,153$5.75$933k7,759,538Dec 3, 2025
Nov 17, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-112,500$7.51$845k7,971,691Nov 28, 2025
Nov 25, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-50,000$5.77$288k7,921,691Nov 28, 2025
Sep 8, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-81,076$8.53$691k7,234,378Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
MOption exercise
Common Stock10b5-1
+216,000$2.00$432k7,450,378Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
FTax withholding
Common Stock10b5-1
-50,644$8.53$432k7,399,734Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
MOption exercise
Common Stock10b5-1
+1,000,000$2.00$2.0M8,399,734Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
FTax withholding
Common Stock10b5-1
-234,466$8.53$2.0M8,165,268Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-81,077$8.39$680k8,084,191Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-216,000$0.00$00Sep 10, 2025
Sep 9, 2025ASPI
ASP Isotopes Inc.
MOption exercise
Employee Stock Option (right to buy)derivative10b5-1
-1,000,000$0.00$00Sep 10, 2025
Apr 15, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-316,667$5.75$1.8M7,948,787Apr 17, 2025
Apr 16, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-316,667$5.45$1.7M7,632,120Apr 17, 2025
Apr 17, 2025ASPI
ASP Isotopes Inc.
SOpen-market sale
Common Stock10b5-1
-316,666$5.62$1.8M7,315,454Apr 17, 2025
Apr 14, 2025ASPI
ASP Isotopes Inc.
AGrant or award
Common Stock
+1,441,361--8,265,454Apr 15, 2025

Questions about Paul Elliot Mann

Answered from the filings on this page, as of the latest one.

Is Paul Elliot Mann buying or selling?

In the last 12 months Paul Elliot Mann reported 0 open-market buys worth $0 and 5 open-market sells worth $6.0M on SEC Form 4; the latest was sold $999k of ASPI on Sep 2, 2026. Grants, option exercises and tax withholding are not counted.

How did Paul Elliot Mann's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Paul Elliot Mann has 0.

Where does Paul Elliot Mann file Form 4?

Paul Elliot Mann has filed Form 4 at ASPI (ASP Isotopes Inc.) as Chairman and CEO. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.